Axogen files underwriting agreement for $49.1M common stock offering
Axogen Inc. announced an underwriting agreement for the sale of 4,910,000 shares of common stock, with net proceeds to fund a BioCircuit Technologies acquisition and general corporate purposes.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day